ZA922482B - Pharmacologically enhanced formulations - Google Patents

Pharmacologically enhanced formulations

Info

Publication number
ZA922482B
ZA922482B ZA922482A ZA922482A ZA922482B ZA 922482 B ZA922482 B ZA 922482B ZA 922482 A ZA922482 A ZA 922482A ZA 922482 A ZA922482 A ZA 922482A ZA 922482 B ZA922482 B ZA 922482B
Authority
ZA
South Africa
Prior art keywords
enhanced formulations
pharmacologically
pharmacologically enhanced
formulations
micronized
Prior art date
Application number
ZA922482A
Other languages
English (en)
Inventor
Sung J Lee
J Lee Sung
Original Assignee
Biofor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofor Ltd filed Critical Biofor Ltd
Publication of ZA922482B publication Critical patent/ZA922482B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cosmetics (AREA)
  • Lubricants (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
ZA922482A 1991-04-05 1992-04-03 Pharmacologically enhanced formulations ZA922482B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/680,997 US5271944A (en) 1991-04-05 1991-04-05 Pharmacologically enhanced formulations

Publications (1)

Publication Number Publication Date
ZA922482B true ZA922482B (en) 1992-12-30

Family

ID=24733350

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA922482A ZA922482B (en) 1991-04-05 1992-04-03 Pharmacologically enhanced formulations

Country Status (16)

Country Link
US (1) US5271944A (fr)
EP (1) EP0599914B1 (fr)
AT (1) ATE155687T1 (fr)
AU (1) AU1876792A (fr)
CA (1) CA2052901C (fr)
CH (1) CH683824A5 (fr)
DE (1) DE69221150T2 (fr)
DK (1) DK0599914T3 (fr)
ES (1) ES2108130T3 (fr)
FR (1) FR2674754B1 (fr)
IE (1) IE74211B1 (fr)
IT (1) ITTO920303A1 (fr)
NZ (1) NZ242233A (fr)
PT (1) PT100329B (fr)
WO (1) WO1992017163A1 (fr)
ZA (1) ZA922482B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
DE69624559T2 (de) * 1995-02-28 2003-07-10 Aventis Pharmaceuticals Inc., Bridgewater Arzneizubereitungen für piperidinalkanolderivate
EP0998272B1 (fr) * 1997-08-26 2003-05-02 Aventis Pharmaceuticals Inc. Composition pharmaceutique associant piperidino-alcanol et decongestionnant
IL152411A0 (en) * 2000-04-24 2003-05-29 Teva Pharma Zolpidem hemitartrate
EP1475093B1 (fr) 2000-04-24 2006-09-06 Teva Pharmaceutical Industries Ltd. Zolpidem Hemitartrate micronisé
JP2004537506A (ja) 2001-03-01 2004-12-16 ホリス − イーデン ファーマスーティカルズ、 インコーポレイテッド 血液細胞欠乏症を治療するためのある種のステロイドの使用
US20060280761A1 (en) * 2002-03-11 2006-12-14 Health Plus International, Inc. Nanofluidized B-12 composition and process for treating pernicious anemia
US6861066B2 (en) * 2002-03-11 2005-03-01 Health Plus International Inc. Method for the delivery of a biologically active agent
BE1015641A4 (fr) * 2003-05-26 2005-07-05 Mariani Jean Paul Micronisation 70.
ES2284068T3 (es) * 2003-10-16 2007-11-01 Teva Pharmaceutical Industries Limited Preparacion de candesartan cilexetilo.
CA2552003A1 (fr) * 2004-01-05 2005-07-28 Teva Pharmaceutical Industries Ltd. Procedes de fabrication de sildenafil base et de son sel citrate
CA2555294A1 (fr) * 2004-02-11 2005-08-25 Marina Yu Etinger Polymorphes de candesartan cilexetil
AU2005330504B2 (en) 2004-09-29 2010-10-28 Harbor Biosciences, Inc. Steroid analogs and characterization and treatment methods
CA2728889C (fr) 2008-04-03 2016-06-14 Harbor Biosciences, Inc. Formes a l'etat solide d'un produit pharmaceutique
TW201613888A (en) 2014-09-26 2016-04-16 Helsinn Healthcare Sa Crystalline forms of an NK-1 antagonist

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
DE3204126A1 (de) * 1982-02-06 1983-08-11 Bayer Ag, 5090 Leverkusen Pyrazoloxazine, -thiazine, -chinoline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
US4912093A (en) * 1986-10-01 1990-03-27 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
DE3723327A1 (de) * 1987-07-15 1989-02-02 Hoechst Ag Substituierte thienoimidazol-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer, magenschutzmittel sowie als medikament gegen intestinale entzuendungen
US4892870A (en) * 1988-08-01 1990-01-09 Biofor, Ltd. Oxaza heterocycles and pharmaceutical compositions containing same

Also Published As

Publication number Publication date
CA2052901A1 (fr) 1992-10-06
IE74211B1 (en) 1997-07-16
EP0599914B1 (fr) 1997-07-23
FR2674754A1 (fr) 1992-10-09
NZ242233A (en) 1993-07-27
FR2674754B1 (fr) 1994-01-14
US5271944A (en) 1993-12-21
EP0599914A1 (fr) 1994-06-08
ITTO920303A0 (it) 1992-04-02
CA2052901C (fr) 1997-12-23
DK0599914T3 (da) 1998-03-02
AU1876792A (en) 1992-11-02
DE69221150T2 (de) 1998-02-26
PT100329B (pt) 1999-06-30
PT100329A (pt) 1993-07-30
IE921040A1 (en) 1992-10-07
CH683824A5 (de) 1994-05-31
EP0599914A4 (en) 1994-08-24
WO1992017163A1 (fr) 1992-10-15
ITTO920303A1 (it) 1993-10-02
ES2108130T3 (es) 1997-12-16
DE69221150D1 (de) 1997-09-04
ATE155687T1 (de) 1997-08-15

Similar Documents

Publication Publication Date Title
AU1876792A (en) Pharmacologically enhanced formulations
AP1637A (en) Celecoxib compositions.
MY119365A (en) Novel pharmaceutical combination
TW355683B (en) Composition containing micronized nebivolol
MX9305146A (es) Conjugado de interferon, procedimiento para su preracion y composicion farmaceutica que lo contienen.
CA2104461A1 (fr) Compositions therapeutiques de protection et de reanimation de cellules de mammiferes et methode pour leur preparation et utilisation
AU531878B2 (en) Medicated animal feed based on liver meal
MY109512A (en) Pharmaceutical composition
SE8700499D0 (sv) Novel pharmacologically active compounds
BRPI0108435B8 (pt) formulação e uso de entecavir de baixa dose
IL101883A0 (en) Antiviral combinations and pharmaceutical compositions containing them
BR9406514A (pt) Composições terapeuticas de nadh e nadh estáveis que podem ser ingeridas e absorvidas
DK0598770T3 (da) Pyrazinderivater samt fremstilling og anvendelse deraf
GR3019274T3 (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
IT9019112A1 (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
CA2135179A1 (fr) Compositions pharmaceutiques d'agonistes 5ht1 de type alkylsulfonamides, pour administration rectale
JPS5781409A (en) External plaster
TW366284B (en) Pharmaceutical antitussive composition of delta-receptor antagonist
ATE136778T1 (de) Oral anzuwendende arzneimittel dapiprazol enthaltend
IL70407A (en) Synergistic analgesic pharmaceutical compositions in unit dosage form,comprising an analgesic agent and hydroxyzine
ATE145333T1 (de) Hirudin enthaltende orale arzneimittel
DK0483320T3 (da) Farmaceutiske sammensætninger med forlænget frigivelse til peroral indgivelse og fremgangsmåde til fremstilling deraf
DE68903713D1 (de) Dextrorphansalze enthaltende orale arzneimittel.
ES2135424T3 (es) Composicion oral a base de ibuprofeno.
SE8700829D0 (sv) Pharmaceutical composition